Antibody-Drug-Conjugates: State-of-the-Art Cancer Treatments

Antibody-Drug-Conjugates: State-of-the-Art Cancer Treatments

Datum: Available in the members area
Beginn/Ende: 1,5 hours
Ort: virtual


The E-Learning on ADCs in Breast Cancer Treatment hosted by ABCSG-president Prof. Dr. Michael Gnant is a joint project of ABCSG and Daiichi-Sankyo. In this on demand continuing education format with three lectures followed by a panel discussion you will learn about the advancements with next generation ADCs, the successful management of adverse events as well as current standards and future perspectives in HER2-treatment.

Duration of the video approx. 1,5 hours.

The demand-video is now → available in the members area!       


Download program

Online Portal

Access the E-Learning via the ABCSG Members Area (Health Care Professional only). If you are interested and not registered yet, you can register via Otherwise, please log in via

Mehr Beiträge zum Thema:

Teilen auf